Satellite Symposia / Sponsored Sessions

Satellite Symposia

Amgen
Harnessing the immune system in ALL: the role of T-cell engagement

Astellas
Viewpoints on the management of infectious complications

Cell Medica
T Cell Therapy – What Does the Future Hold?

CTI LifeSciences
Is Salvage Therapy Possible in Patients with DLBCL After Failure of Standard Second Line Regimens?

Gentium
Can severe hepatic veno-occlusive disease (VOD) ever be treated effectively? Exploring the data behind a new treatment approach

Gilead
Considering the host: Risk factors for fungal infections

Kiadis Pharma
Effective T-cell immunotherapy with ATIR™ after haploidentical HSCT: Excellent OS with low GvHD

Medac Hematology
TREOSULFAN - A Conditioning Agent On Its Way to an Established Alternative in Stem Cell Transplantation

Merck Sharpe & Dohme (MSD)
Evidence based management strategies for Invasive Fungal Infections in the Hematology patient

Miltenyi Biotec
Cellular therapy: Facts, developments, and future visions

Neovii-Biotech
Monitoring and managing of acute leukemia relapse after T-cell depleted allogeneic SCT

Pierre Fabre Medicament
Hematological malignancies : from allo transplant to life after transplant

Sanofi
Progress in GVHD Prophylaxis

Sanofi
Stem Cell Mobilization: from science to clinical practice

Takeda
Managing the relapsed/refractory lymphoma patient in the era of targeted therapies

Nurses Group Symposium

Gentium
Active management of veno-occlusive disease: what should you do now?

Spotlight Session

French Society of Bone Marrow Transplantation and Cell Therapies / Societe de Greffe de Moelle et de Therapie Cellulaire
Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome

Intergroupe Francophone du Myelome (IFM) and the Institut Universitaire de Cancerologie (IUC)
The latest advances in multiple myeloma: the IFM perspective

Lunch Controversies

Celgene
Post-allogeneic HSCT treatment with hypomethylators in AML patients: before or after relapse?

Sanofi Aventis Groupe
Is chemotherapy needed for stem cell mobilization in multiple myeloma?

© 2013 EBMT 2014. All Rights Reserved. -- Design & Production: FUTURMEDIA